TrialBreast cancer research and treatment2015

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.

C C Engels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.